Literature DB >> 22171061

Characterization of ppGalNAc-T18, a member of the vertebrate-specific Y subfamily of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases.

Xing Li1, Jing Wang, Wei Li, Yingjiao Xu, Dong Shao, Yinyin Xie, Wenxian Xie, Tomomi Kubota, Hisashi Narimatsu, Yan Zhang.   

Abstract

The first step of mucin-type O-glycosylation is catalyzed by members of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-T; EC 2.4.1.41) family. Each member of this family has unique substrate specificity and expression profiles. In this report, we describe a new subfamily of ppGalNAc-Ts, designated the Y subfamily. The Y subfamily consists of four members, ppGalNAc-T8, -T9, -T17 and -T18, in which the conserved YDX(5)WGGENXE sequence in the Gal/GalNAc-T motif of ppGalNAc-Ts is mutated to LDX(5)YGGENXE. Phylogenetic analysis revealed that the Y subfamily members only exist in vertebrates. All four Y subfamily members lack in vitro GalNAc-transferase activity toward classical substrates possibly because of the UDP-GalNAc-binding pocket mutants. However, ppGalNAc-T18, the newly identified defining member, was localized in the endoplasmic reticulum rather than the Golgi apparatus in lung carcinoma cells. The knockdown of ppGalNAc-T18 altered cell morphology, proliferation potential and changed cell O-glycosylation. ppGalNAc-T18 can also modulate the in vitro GalNAc-transferase activity of ppGalNAc-T2 and -T10, suggesting that it may be a chaperone-like protein. These findings suggest that the new Y subfamily of ppGalNAc-Ts plays an important role in protein glycosylation; characterizing their functions will provide new insight into the role of ppGalNAc-Ts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171061     DOI: 10.1093/glycob/cwr179

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  18 in total

1.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

2.  UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.

Authors:  Jayalakshmi Raman; Yu Guan; Cynthia L Perrine; Thomas A Gerken; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-20       Impact factor: 4.313

Review 3.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.

Authors:  Eric P Bennett; Ulla Mandel; Henrik Clausen; Thomas A Gerken; Timothy A Fritz; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-18       Impact factor: 4.313

4.  A putative polypeptide N-acetylgalactosaminyltransferase/Williams-Beuren syndrome chromosome region 17 (WBSCR17) regulates lamellipodium formation and macropinocytosis.

Authors:  Yoshiaki Nakayama; Naosuke Nakamura; Sayoko Oki; Masaki Wakabayashi; Yasushi Ishihama; Ayumi Miyake; Nobuyuki Itoh; Akira Kurosaka
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

Review 5.  Polypeptide N-acetylgalactosamine transferase 3: a post-translational writer on human health.

Authors:  Yohana Camila Garay; Romina Beatriz Cejas; Virginia Lorenz; Natacha Zlocowski; Pedro Parodi; Franco Alejandro Ferrero; Genaro Angeloni; Valentina Alfonso García; Victor German Sendra; Ricardo Dante Lardone; Fernando José Irazoqui
Journal:  J Mol Med (Berl)       Date:  2022-09-02       Impact factor: 5.606

Review 6.  Polypeptide GalNAc-Ts: from redundancy to specificity.

Authors:  Matilde de Las Rivas; Erandi Lira-Navarrete; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Curr Opin Struct Biol       Date:  2019-01-28       Impact factor: 6.809

7.  Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin.

Authors:  Yingjiao Xu; Wenjie Pang; Jishun Lu; Aidong Shan; Yan Zhang
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

8.  Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.

Authors:  Leslie Revoredo; Shengjun Wang; Eric Paul Bennett; Henrik Clausen; Kelley W Moremen; Donald L Jarvis; Kelly G Ten Hagen; Lawrence A Tabak; Thomas A Gerken
Journal:  Glycobiology       Date:  2015-11-26       Impact factor: 4.313

9.  The small molecule luteolin inhibits N-acetyl-α-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein.

Authors:  Feng Liu; Kai Xu; Zhijue Xu; Matilde de Las Rivas; Congrong Wang; Xing Li; Jishun Lu; Yueyang Zhou; Ignacio Delso; Pedro Merino; Ramon Hurtado-Guerrero; Yan Zhang; Fang Wu
Journal:  J Biol Chem       Date:  2017-10-23       Impact factor: 5.157

10.  Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.

Authors:  Sylvain Lehoux; Rongjuan Mi; Rajindra P Aryal; Yingchun Wang; Katrine T-B G Schjoldager; Henrik Clausen; Irma van Die; Yoosun Han; Arlene B Chapman; Richard D Cummings; Tongzhong Ju
Journal:  Mol Cell Proteomics       Date:  2014-07-28       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.